Antigen-based diagnosis of Schistosoma infection in travellers: a prospective study.
Adult
Africa South of the Sahara
Animals
Antibodies, Helminth
/ blood
Antigens, Helminth
/ blood
Enzyme-Linked Immunosorbent Assay
/ standards
Female
Humans
Male
Prospective Studies
Schistosoma
/ immunology
Schistosoma mansoni
/ immunology
Schistosomiasis mansoni
/ blood
Sensitivity and Specificity
Serologic Tests
/ standards
Travel-Related Illness
Schistosomiasis
circulating anodic antigen (CAA)
freshwater contact
praziquantel
questionnaire
serology
Journal
Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456
Informations de publication
Date de publication:
14 Jul 2020
14 Jul 2020
Historique:
received:
02
03
2020
revised:
09
04
2020
accepted:
10
04
2020
pubmed:
21
4
2020
medline:
17
6
2021
entrez:
21
4
2020
Statut:
ppublish
Résumé
Travellers infected with Schistosoma spp. might be pauci- or even asymptomatic on first presentation. Therefore, schistosomiasis may remain undiagnosed in this population. Active infection, as evidenced by the presence of the tissue-dwelling worm, can be demonstrated via the detection of adult worm-derived circulating anodic antigen (CAA) utilising a robust well-described lateral flow-(LF) based test applying background-free up-converting reporter particles (UCP). In this prospective study, we assessed the diagnostic value of serum and urine UCP-LF CAA test in comparison with two Schistosoma-specific serological assays detecting antibodies against adult worm antigen-immuno fluorescence assay (AWA-IFA) and against soluble egg antigen-enzyme-linked immunosorbent assay (SEA-ELISA) antigens in travellers. Samples were collected from 106 Dutch travellers who reported freshwater contact in sub-Saharan Africa and who were recruited up to 2 years after return. Subjects were asked to complete a detailed questionnaire on travel history, water contact, signs and symptoms compatible with schistosomiasis. Two travellers were positive by serum CAA and an additional one by urine CAA. A total of 22/106 (21%) samples were antibody positive by AWA-IFA and 9/106 (9%) by SEA-ELISA. At follow-up 6 weeks and 6 months after praziquantel treatment, all seropositives remained antibody positive whereas CAA was cleared. Seropositivity could not be predicted by the type of fresh water-related activity, country visited or symptoms reported. The low number of UCP-LF CAA positives suggests that in travellers, active infections often do not establish or have very low worm burden. Based on our high seroconversion rates, we conclude that the AWA-IFA assay is the most sensitive test to detect schistosome exposure. Given the lack of predictive symptoms or risk factors, we recommend schistosomiasis screening at least by serology in all travellers with reported freshwater contact in high-endemic areas.
Sections du résumé
BACKGROUND
BACKGROUND
Travellers infected with Schistosoma spp. might be pauci- or even asymptomatic on first presentation. Therefore, schistosomiasis may remain undiagnosed in this population. Active infection, as evidenced by the presence of the tissue-dwelling worm, can be demonstrated via the detection of adult worm-derived circulating anodic antigen (CAA) utilising a robust well-described lateral flow-(LF) based test applying background-free up-converting reporter particles (UCP). In this prospective study, we assessed the diagnostic value of serum and urine UCP-LF CAA test in comparison with two Schistosoma-specific serological assays detecting antibodies against adult worm antigen-immuno fluorescence assay (AWA-IFA) and against soluble egg antigen-enzyme-linked immunosorbent assay (SEA-ELISA) antigens in travellers.
METHODS
METHODS
Samples were collected from 106 Dutch travellers who reported freshwater contact in sub-Saharan Africa and who were recruited up to 2 years after return. Subjects were asked to complete a detailed questionnaire on travel history, water contact, signs and symptoms compatible with schistosomiasis.
RESULTS
RESULTS
Two travellers were positive by serum CAA and an additional one by urine CAA. A total of 22/106 (21%) samples were antibody positive by AWA-IFA and 9/106 (9%) by SEA-ELISA. At follow-up 6 weeks and 6 months after praziquantel treatment, all seropositives remained antibody positive whereas CAA was cleared. Seropositivity could not be predicted by the type of fresh water-related activity, country visited or symptoms reported.
CONCLUSION
CONCLUSIONS
The low number of UCP-LF CAA positives suggests that in travellers, active infections often do not establish or have very low worm burden. Based on our high seroconversion rates, we conclude that the AWA-IFA assay is the most sensitive test to detect schistosome exposure. Given the lack of predictive symptoms or risk factors, we recommend schistosomiasis screening at least by serology in all travellers with reported freshwater contact in high-endemic areas.
Identifiants
pubmed: 32307517
pii: 5822102
doi: 10.1093/jtm/taaa055
pmc: PMC7359925
pii:
doi:
Substances chimiques
Antibodies, Helminth
0
Antigens, Helminth
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© International Society of Travel Medicine 2020.
Références
Clin Microbiol Infect. 2015 Jun;21(6):529-42
pubmed: 25843503
Scand J Infect Dis. 2009;41(4):285-90
pubmed: 19221932
Trans R Soc Trop Med Hyg. 2000 Sep-Oct;94(5):531-4
pubmed: 11132383
Travel Med Infect Dis. 2012 Jul;10(4):172-8
pubmed: 22647772
Am J Trop Med Hyg. 1980 May;29(3):401-10
pubmed: 6992609
J Travel Med. 2005 Sep-Oct;12(5):265-9
pubmed: 16256050
Am J Trop Med Hyg. 2014 May;90(5):835-9
pubmed: 24615130
Curr Infect Dis Rep. 2013 Jun;15(3):211-5
pubmed: 23568567
J Travel Med. 2010 Mar-Apr;17(2):94-9
pubmed: 20412175
Trop Med Parasitol. 1990 Sep;41(3):257-61
pubmed: 2123993
Trans R Soc Trop Med Hyg. 1989 May-Jun;83(3):364-7
pubmed: 2515624
Parasitology. 1997 Jul;115 ( Pt 1):29-32
pubmed: 9226954
PLoS Negl Trop Dis. 2015 Jul 28;9(7):e0003959
pubmed: 26217948
Lancet. 1996 Nov 9;348(9037):1274-8
pubmed: 8909380
Acta Trop. 2000 Oct 23;77(1):69-80
pubmed: 10996122
Parasitology. 1965 Nov;55(4):695-700
pubmed: 4957633
Parasitology. 2014 Dec;141(14):1841-55
pubmed: 24932595
Exp Parasitol. 2013 Oct;135(2):274-82
pubmed: 23850995
Lancet. 2014 Jun 28;383(9936):2253-64
pubmed: 24698483
Ann Trop Med Parasitol. 2008 Oct;102(7):625-33
pubmed: 18817603
J Travel Med. 2005 Jan-Feb;12(1):9-13
pubmed: 15996461
BMC Med Educ. 2010 Dec 02;10:89
pubmed: 21126347
Travel Med Infect Dis. 2011 Jan;9(1):6-24
pubmed: 21216199
Rev Med Interne. 2006 Aug;27(8):595-9
pubmed: 16822596
Am J Trop Med Hyg. 2017 Aug;97(2):567-574
pubmed: 28722637
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1709-1716
pubmed: 29974279
Trans R Soc Trop Med Hyg. 1986;80(3):435-8
pubmed: 3099436
Int J Infect Dis. 2017 Jan;54:130-137
pubmed: 27939558
Acta Leiden. 1973;39:5-107
pubmed: 4573511
J Travel Med. 2014 Mar-Apr;21(2):133-6
pubmed: 24455977
Am J Trop Med Hyg. 2008 Nov;79(5):729-34
pubmed: 18981513
Nat Med. 2020 Mar;26(3):326-332
pubmed: 32066978